127 related articles for article (PubMed ID: 23303441)
1. Evaluation of hepatic disposition of paroxetine using sandwich-cultured rat and human hepatocytes.
Matsunaga N; Nunoya K; Okada M; Ogawa M; Tamai I
Drug Metab Dispos; 2013 Apr; 41(4):735-43. PubMed ID: 23303441
[TBL] [Abstract][Full Text] [Related]
2. An experimental approach to evaluate the impact of impaired transport function on hepatobiliary drug disposition using Mrp2-deficient TR- rat sandwich-cultured hepatocytes in combination with Bcrp knockdown.
Yang K; Pfeifer ND; Hardwick RN; Yue W; Stewart PW; Brouwer KL
Mol Pharm; 2014 Mar; 11(3):766-75. PubMed ID: 24410402
[TBL] [Abstract][Full Text] [Related]
3. Hepatobiliary disposition of troglitazone and metabolites in rat and human sandwich-cultured hepatocytes: use of Monte Carlo simulations to assess the impact of changes in biliary excretion on troglitazone sulfate accumulation.
Lee JK; Marion TL; Abe K; Lim C; Pollock GM; Brouwer KL
J Pharmacol Exp Ther; 2010 Jan; 332(1):26-34. PubMed ID: 19801447
[TBL] [Abstract][Full Text] [Related]
4. Hepatocellular exposure of troglitazone metabolites in rat sandwich-cultured hepatocytes lacking Bcrp and Mrp2: interplay between formation and excretion.
Yang K; Brouwer KL
Drug Metab Dispos; 2014 Jul; 42(7):1219-26. PubMed ID: 24799397
[TBL] [Abstract][Full Text] [Related]
5. Development of a Rat Sandwich-Cultured Hepatocytes Model Expressing Functional Human Organic Anion Transporting Polypeptide (OATP) 1B3: A Potential Screening Tool for Liver-Targeting Compounds.
Farasyn T; Xu C; Yue W
J Pharm Pharm Sci; 2021; 24():475-483. PubMed ID: 34516949
[TBL] [Abstract][Full Text] [Related]
6. Effect of Cryopreservation on Enzyme and Transporter Activities in Suspended and Sandwich Cultured Rat Hepatocytes.
Keemink J; Deferm N; De Bruyn T; Augustijns P; Bouillon T; Annaert P
AAPS J; 2018 Feb; 20(2):33. PubMed ID: 29468289
[TBL] [Abstract][Full Text] [Related]
7. Species differences in hepatobiliary disposition of taurocholic acid in human and rat sandwich-cultured hepatocytes: implications for drug-induced liver injury.
Yang K; Pfeifer ND; Köck K; Brouwer KL
J Pharmacol Exp Ther; 2015 May; 353(2):415-23. PubMed ID: 25711339
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of (99m)technetium-mebrofenin and (99m)technetium-sestamibi as specific probes for hepatic transport protein function in rat and human hepatocytes.
Swift B; Yue W; Brouwer KL
Pharm Res; 2010 Sep; 27(9):1987-98. PubMed ID: 20652625
[TBL] [Abstract][Full Text] [Related]
9. Mathematical modeling of the in vitro hepatic disposition of mycophenolic acid and its glucuronide in sandwich-cultured human hepatocytes.
Matsunaga N; Wada S; Nakanishi T; Ikenaga M; Ogawa M; Tamai I
Mol Pharm; 2014 Feb; 11(2):568-79. PubMed ID: 24320552
[TBL] [Abstract][Full Text] [Related]
10. Glucuronidation and subsequent biliary excretion of mycophenolic acid in rat sandwich-cultured hepatocytes.
Tetsuka K; Gerst N; Tamura K; Masters JN
Drug Metab Pharmacokinet; 2014; 29(2):129-34. PubMed ID: 24025987
[TBL] [Abstract][Full Text] [Related]
11. Endogenous bile acid disposition in rat and human sandwich-cultured hepatocytes.
Marion TL; Perry CH; St Claire RL; Brouwer KL
Toxicol Appl Pharmacol; 2012 May; 261(1):1-9. PubMed ID: 22342602
[TBL] [Abstract][Full Text] [Related]
12. Use of cassette dosing in sandwich-cultured rat and human hepatocytes to identify drugs that inhibit bile acid transport.
Wolf KK; Vora S; Webster LO; Generaux GT; Polli JW; Brouwer KL
Toxicol In Vitro; 2010 Feb; 24(1):297-309. PubMed ID: 19706322
[TBL] [Abstract][Full Text] [Related]
13. Sandwich-Cultured Hepatocytes as a Tool to Study Drug Disposition and Drug-Induced Liver Injury.
Yang K; Guo C; Woodhead JL; St Claire RL; Watkins PB; Siler SQ; Howell BA; Brouwer KLR
J Pharm Sci; 2016 Feb; 105(2):443-459. PubMed ID: 26869411
[TBL] [Abstract][Full Text] [Related]
14. Mechanistic Basis of Cabotegravir-Glucuronide Disposition in Humans.
Patel M; Eberl HC; Wolf A; Pierre E; Polli JW; Zamek-Gliszczynski MJ
J Pharmacol Exp Ther; 2019 Aug; 370(2):269-277. PubMed ID: 31175220
[TBL] [Abstract][Full Text] [Related]
15. Mechanistic Modeling of the Hepatic Disposition of Estradiol-17
Ito K; Sjöstedt N; Brouwer KLR
Drug Metab Dispos; 2020 Feb; 48(2):116-122. PubMed ID: 31744810
[TBL] [Abstract][Full Text] [Related]
16. In vitro model systems to investigate bile salt export pump (BSEP) activity and drug interactions: A review.
Cheng Y; Woolf TF; Gan J; He K
Chem Biol Interact; 2016 Aug; 255():23-30. PubMed ID: 26683212
[TBL] [Abstract][Full Text] [Related]
17. Decreased hepatic breast cancer resistance protein expression and function in multidrug resistance-associated protein 2-deficient (TR⁻) rats.
Yue W; Lee JK; Abe K; Sugiyama Y; Brouwer KL
Drug Metab Dispos; 2011 Mar; 39(3):441-7. PubMed ID: 21106720
[TBL] [Abstract][Full Text] [Related]
18. The hepatobiliary disposition of timosaponin b2 is highly dependent on influx/efflux transporters but not metabolism.
Sheng J; Tian X; Xu G; Wu Z; Chen C; Wang L; Pan L; Huang C; Pan G
Drug Metab Dispos; 2015 Jan; 43(1):63-72. PubMed ID: 25336752
[TBL] [Abstract][Full Text] [Related]
19. Assessment of drug interactions in hepatobiliary transport using rhodamine 123 in sandwich-cultured rat hepatocytes.
Annaert PP; Brouwer KL
Drug Metab Dispos; 2005 Mar; 33(3):388-94. PubMed ID: 15608134
[TBL] [Abstract][Full Text] [Related]
20. Sulindac and its metabolites inhibit multiple transport proteins in rat and human hepatocytes.
Lee JK; Paine MF; Brouwer KL
J Pharmacol Exp Ther; 2010 Aug; 334(2):410-8. PubMed ID: 20430841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
